Alendronate Sodium is a bisphosphonate that inhibits osteoclast-mediated bone resorption, used to treat osteoporosis and Paget’s disease of bone. Alendronate Sodium is the sodium salt of alendronate, a second generation bisphosphonate and synthetic analog of pyrophosphate with bone anti-resorption activity. It is grouped under the following drug class(es): Bisphosphonates. Its therapeutic use is listed as anti-osteoporosis agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Alendronate monosodium trihydrate, Alendronate sodium, Adronat, Adrovance, Vantavo and Fosavance. Its PubChem CID is 23681107.
Alendronate sodium trihydrate
| CAS No | 121268-17-5 |
|---|---|
| Molecular Formula | C4H18NNaO10P2 |
| Molecular Weight | 325.12 g/mol |
| Synonyms | sodium;(4-amino-1-hydroxy-1-phosphonobutyl)-hydroxyphosphinate;trihydrate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Alendronate Sodium is a bisphosphonate that inhibits osteoclast-mediated bone resorption, used to treat osteoporosis and Paget's disease of bone. Alendronate Sodium is the sodium salt of alendronate, a second generation bisphosphonate and synthetic analog of pyrophosphate with bone anti-resorption activity.
The listed CAS number is 121268-17-5.
The listed molecular formula is C4H18NNaO10P2.
The listed molecular weight is 325.12 g/mol.
sodium;(4-amino-1-hydroxy-1-phosphonobutyl)-hydroxyphosphinate;trihydrate.
The source lists Alendronate monosodium trihydrate, Alendronate sodium, Adronat, Adrovance, Vantavo and Fosavance.